chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I just began having a sore throat and didn't really have any other symptoms other than the progressive soreness of my throat. I took a at home covid test and I tested negative. My throat just getting more sore so I took another test and it was negative. The next morning, I really had a sore throat with congestion in the chest and head, swollen glands behind my ears. I took 3rd covid test and it was negative. I went to Urgent Care and was seen by Dr. and he ran a strep test and it was negative. I had another covid test and it was negative. He diagnosed it with laryngitis. I still have nasal drip and productive loose cough and never had a temperature this whole time.
Information has been received from a Nurse Practitioner concerning a 15 year old female patient who on 28-DEC-2009 received her first dose of GARDASIL 0.5mL (lot# 663453/0249Y) into her left deltoid muscle and concomitantly received a dose of MENACTRA (lot# 03058AA). The nurse practitioner reported that after receiving the vaccinations, the patient had a brief loss of consciousness and went into a tonic clonic movement. After the patient recovered from that, and she lost consciousness again an then recovered. In follow-up, it was also reported by the Nurse Practitioner that the patient "passed out" for about 10 to 15 seconds and had a tonic clonic movement for about 10 to 15 seconds. The patient regained consciousness and "passed out" again for about 10 to 15 seconds. The patient regained consciousness and recovered. Follow up information has been received from the nurse practitioner who indicated that the patient was a female student with no allergies and otherwise healthy who on 28-DEC-2009 was vaccinated intramuscularly with the first dose of GARDASIL into her left deltoid at 09:40 AM. On the same day, the patient was administered the first dose of MENACTRA (lot# 03058AA) given intramuscularly into her right deltoid at 09:40. No illness were reported at the time of vaccination. It was reported that on 28-DEC-2009, at 09:40 the patient experienced a syncopal episode with tonic-clonic movements. The patient recovered on 28-DEC-2009. Additional information is not expected.
Injection via percutaenous at unknown location. Pt arrived to Immunizations clinic approx 9 days after vaccination with redness/swellin at vaccination site, redness radiating up left arm on to chest. Pt was referred to family health provider and treated for cellulitis. Pt stated 13 days after vaccination pt started having headaches and fevers and was seen at another hospital. Pt was admitted to the hospital for 24 hours. Pt states she had a rash on her back. I am unsure if she said it was before she was admitted or during. She states it might have been caused from medications given during hospital visit.
Vaccinated on 1/16/21-Underarm pain and swelling beginning day 4 (1/20/21) after vaccine followed by swollen, hot, itchy pain around injection site on day 7 (1/24/21)after vaccine
Vaccines were given 1/5/05 with IPV and P - 7 in left thigh. The next day, pt wouldn't walk or bear weight on left leg. Pt returned for f/u and was referred to the hospital on 1/8 and diagnosed with toxic synovitis. On 1/11, he was referred back to the hospital and had a septic hip infection.
Positive COVID-19 test with symptoms; Positive COVID-19 test with symptoms; This is a spontaneous report from a contactable consumer (patient).  A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), dose 1, via an unspecified route of administration on 21Mar2021 (Batch/Lot number was not reported) as SINGLE DOSE for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced Positive COVID-19 test with symptoms on an unspecified date with clinical course of post-nasal drip and started to have a fever prior to the second dose on an unknown date. The patient underwent lab tests and procedures which included body temperature: 99.7, 99.2 and 99.3 on unknown dates and she tested positive for COVID on an unknown date. The clinical outcome of the event COVID-19 was unknown.    No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Rt upper arm redness, warmth, pain, and mild edema. S/s developed evening of vaccine administration per patient report. Tx - continue to monitor and if worsening seek f/u care - Emergent if needed with s/s of severe oraphylaxis educ. provided.
Developed pain under right arm, by shoulder blade, lasted 4 days, then same pain under left arm still on going, no redness, just burning.
the patient had mild soreness with his first coronavirus vaccine on July 24, 2021.  The second Pfizer coronavirus vaccine was administered on August 14, 2021.  He immediately had some soreness at the vaccine site and shortly after the vaccine, within 3 days he had shortness of breath and chest pressure, diffuse muscle aches and arthralgias.  He had shooting sharp pains in all of his extremities and especially achiness in his knees.  The patient also had a moderate to severe headache for several weeks following the vaccine. He denies shortness of breath or chest pain but did have severe increase of overall fatigue and malaise.  He had cognitive impairment and worsened short-term memory and difficulty with long-term memory recall that has persisted since that vaccine.  He has had trouble with loose stools up to 3 times a week since that time.  He denies any blood in his stools.  He has had palpitations without any severe dizziness although he does feel lightheaded much of the time.  All of his symptoms are disabling and he has been unable to work for the past month because of these symptoms. The symptoms persist to date and wax and wane in severity.  They remain disabling.
Tested positive for the Covid 19 virus; This is a spontaneous report from a contactable consumer (patient) from marketing programme. A 49-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, lot Number and expiration date unknown), via an unspecified route of administration administered in Arm Left on 06Mar2021 12:15 as single dose for covid-19 immunization. The patient medical history and concomitant medications were none. Caller stated that he received first shot of Covid vaccine on 06Mar2021 and tested positive for the Covid 19 virus (sars-cov-2 test positive) (medically significant) on 12Mar2021.  The caller further mentioned that he is scheduled for the second shot this weekend on 27Mar2021 and was asking if it is ok to get the second vaccine. He called the main number for Pfizer and was transferred to Pfizer Drug Safety. He has also called his doctor and his doctor did not have an answer regarding whether he should get the second vaccine. The patient underwent lab tests which included on 12Mar2021, he underwent rapid Covid 19 test and in Mar2021, an unspecified Covid 19 test; both results were positive.The outcome of event was unknown.  Information on the lot/batch number has been requested.
Patient came into our vaccination clinic we were having for youth.  He asked about getting the vaccine for himself as well.  Since he was an adult Moderna vaccine was offered to him. He stated he had not received the vaccine previously and would like to get vaccinated.  He completed the vaccine form and indicated he had not received a COVID vaccine.  Moderna vaccine was given to the patient thinking he was receiving his 1st dose by RN.  When entering data into the system, it was discovered that patient had received a Moderna COVID vaccine 5 days prior.  This was not immediately brought to my attention.  I was just notified today.  I have attempted to call patient to notify him but there was no answer.
Pt Came to outdoor clinic and received Janssen Vaccine in a her left arm seated in a chair.  Five minutes later patient felt dizzy and passed out.  Patient was lowered to the floor and woke back up immediately. Pt remained in a lying position and was slowly helped up into a sitting position. Pt stated she felt dizzy once again and passed out.  Pt again immediately came to and stated she was embarased. Pt remained alert and oriented inside the trailer in lying position. Vital signs stable @5:45pm , BP 100/60, P66 ,T96.7, P66.  EMS called to the scene . Vitals taken again at 6:00pm BP 110/70, P55, POx 99. Pt refused to be transported to the hospital and said she feels fine . Pt left with her boyfriend at 6:15 pm
ADMITTED TO HOSPITAL DUE TO INTERMITTENT FEVERS AND DELIRIUM FROM ACUTE REHAB. FEVER 1/15/22 100.9 F
5 days Hx of twitching; involuntary movements - Rubbing head and neck on R shoulder - Took H1N1 - Nasal 2-4-10 can happen up to every 30 secs- Usually occurs when prone. Muscle strength, tone, DTRs, sensation WNL - No upper or lower extremity weakness.
Dry cough; Full blown flue like symptoms.; Sore throat; This spontaneous case was reported by a non-health professional and describes the occurrence of COUGH (Dry cough), INFLUENZA LIKE ILLNESS (Full blown flue like symptoms.) and OROPHARYNGEAL PAIN (Sore throat) in an 87-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medically reported history).    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COUGH (Dry cough), INFLUENZA LIKE ILLNESS (Full blown flue like symptoms.) and OROPHARYNGEAL PAIN (Sore throat). At the time of the report, COUGH (Dry cough), INFLUENZA LIKE ILLNESS (Full blown flue like symptoms.) and OROPHARYNGEAL PAIN (Sore throat) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       There is no concomitant list provided.  No treatment information was provided. A little soon after the vaccination she had dry cough and full blown flu like symptoms. She had sore throat and felt as if she had pneumonia. Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Patient was given expired vaccine. Vaccine was given 11/02/2022 and expired 10/29/2022. Patients parent/guardian was contacted and is now scheduled to receive replacing dose on 12/02/2022.
on day 3 after vaccine patient had heart/chest/breathing hurts and shortness of breath, fever, weak, and got worse as day went on and woke up on day 4 soaked in sweat
2/10/2021 after vaccine, heart rate was 150+ during sleep and elevated above 126 the entire day, headache, fatigue 2/10/2021 visited doctor, told to rest, had take Tylenol
This is in follow-up to report (s) previously submitted on 2/11/2009. Information has been received from a physician concerning a 12 year old female patient who on an unknown date was vaccinated with the first dose of GARDASIL 0.5 mL. After received the first dose of GARDASIL, the patient experienced pain in her whole arm. The patient was sent to the emergency room. On an unspecified date, the patient recovered from pain in her whole arm. Additional information has been requested. Follow up information has been received from the physician concerning the female patient with no illness at the time of vaccination, who on 25-NOV-2008 at the afternoon was vaccinated with the first dose of GARDASIL (Lot number 659657/1480U) IM 0.5 mL. Two-three days after approximately on 27-NOV-2008, the patient experienced severe pain on site of injection. The patient went to the emergency room. A X-ray of humerus was performed (results not provided). The patinet was treated with MOTRIN. No record was faxed to office of the emergency room visit. No further information is available.
Patient presented to us with 3 day history of worsening chest pain, SOB, slight rash on hands/chest/legs, and abdominal pain and diarrhea. Was found to have elevated troponins to 0.35 and a\ which showed appendicitis. Patient was found to be hypotensive and did require a brief period of Norepinephrine, but quickly was able to de-escalate off vasoactive support. He was discharged home.
Received immunizations 6/12/03. Phone call from parent on 8/1/03 after receiving invitation for 8/14/03 shot clinic. Reports patient had high fever and seizure on the way to hospital; was given Tylenol, cool baths to bring fever down. Was told by doctor seizure due to high fever. Had high fever for 2 days after receiving immunizations.
Missed her 2nd dose; Chills; Fever; Body aches; Fatigue, tiredness; Elevated BP; Dizziness; Weakness; This spontaneous case was reported by a nurse and describes the occurrence of BLOOD PRESSURE INCREASED (Elevated BP), DIZZINESS (Dizziness), ASTHENIA (Weakness), PRODUCT DOSE OMISSION ISSUE (Missed her 2nd dose) and CHILLS (Chills) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (while taking care of patients with Covid-19).    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced BLOOD PRESSURE INCREASED (Elevated BP), DIZZINESS (Dizziness), ASTHENIA (Weakness), CHILLS (Chills), PYREXIA (Fever), MYALGIA (Body aches) and FATIGUE (Fatigue, tiredness). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed her 2nd dose). At the time of the report, BLOOD PRESSURE INCREASED (Elevated BP), DIZZINESS (Dizziness), ASTHENIA (Weakness), PRODUCT DOSE OMISSION ISSUE (Missed her 2nd dose), CHILLS (Chills), PYREXIA (Fever), MYALGIA (Body aches) and FATIGUE (Fatigue, tiredness) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 antibody test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were provided.  The patient reported that she missed her second dose due to death in family and due to severe adverse event (AE) she experienced after first dose of vaccination. The patient reported that she felt like Covid-19 all over again after the vaccination. The patient was inquiring about should she get the second dose of vaccination since it has been >42 days and she was positive for Covid-19 antibodies at the time of reporting.  No treatment information was provided.
On 01/18/2023, I went to the emergency room around 03:00PM. For a couple of days prior, I had abdominal pain. I was also running a fever. I called the office first to be seen. They could not see me, so suggested I go to an urgent care with a CT scanner. There was not one available, so we decided to go to the emergency room. Bloodwork showed white blood count 9.93. They gave me fluids with an IV and a CT scan with contrast. They gave me antibiotics.
Syncope about 17 hours after vaccine, about 20 minutes after getting up from sleep.  Had fever in the night (110.4).  Was evaluated at ED -- their conclusion was dehydration from fever leading to syncope. I have passed out before from vaccinations, but many years ago and usually within 5 minutes.  I haven't passed out from dehydration before.  Hence, I am reporting it as vaccine related.
WARM ON THE SECOND DAY AFTER THE SHOT; MILD ACHE; SWEATING ON THE SECOND DAY AFTER THE SHOT; SORE ARM THE FIRST DAY AFTER THE SHOT; This spontaneous report received from a patient concerned a 90 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included: non smoker, abstains from alcohol, sore arm and other pre-existing medical conditions included: Patient was healthy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on APR-2021 for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On APR-2021, the patient experienced warm on the second day after the shot. On APR-2021, the patient experienced mild ache. On APR-2021, the patient experienced sweating on the second day after the shot. On APR-2021, the patient experienced sore arm the first day after the shot. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the sore arm the first day after the shot, warm on the second day after the shot, mild ache and sweating on the second day after the shot was not reported. This report was non-serious.
Patient was admitted on 4/9 to hospital with left facial, upper and lower extremity numbness that last 5 min and resolved. In ED had similar symptoms.  CT head, MRI brain, MRA head and neck unremarkable. Hgb 6.6 and Plt 13.  Transferred to Medical Center on 4/10 for more care. Diagnosed with TIA and possible TTP (ADAMTS13 pending, meets other criteria). Started on high dose methylprednisolone 1000 mg IV x 3 doses on 4/11, plasmapheresis on 4/11, and weekly rituximab on 4/11.  Status/outcomes pending
ANGIOEDEMA; This spontaneous report received from a consumer via other manufacturer (Pfizer Inc.) concerned a female of unspecified age. The patient's height, and weight were not reported.  The patient's concurrent conditions included: mild asthma (Patient had an inhaler and the asthma was diagnosed probably in 2015), and cholesterol abnormal (Patient was taking unspecified medication for cholesterol but once patient's weight went down she discontinued that medication). The patient was not taking any other prescription medications. The patient previously received influenza vaccine for prophylactic vaccination. The patient was taking flu shot every year. She got the flu shot before the covid vaccine, she separated them out. She did not receive them on the same day The patient received covid-19 vaccine ad26.cov2.s (dose number in series 1) (suspension for injection, route of admin, batch number and expiry were not reported) dose was not reported, 1 total, administered on 08-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. Concomitant medications included Albuterol (salbutamol) once a day inhalation by mouth for asthma.  On 08-MAR-2021, the patient experienced urticaria/hives, swelling, and angioedema (dose number in series 1). The swelling and hives lasted three or four months. The patient's primary care physician referred patient to an immunologist. The patient went to the immunologist. The immunologist started patient with antihistamines cetirizine (generic for Zyrtec), and montelukast (generic for Singulair) as a treatment (date unspecified) for angioedema. The patient received additional covid-19 vaccine ad26.cov2.s (Dose number in series 2) (suspension for injection, route of administration, batch number and expiry were not reported) dose was not reported, administered on unspecified date for prophylactic vaccination. No adverse events reported following vaccination with covid-19 vaccine ad26.cov2.s (Dose number in series 2).   The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of angioedema was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20220409138-COVID-19 VACCINE AD26.COV2.S-Angioedema. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and is scientifically plausible. There is no information on any other factors potentially associated with the event(s). Therefore, this event(s) is considered related.
I began getting a headache about 1hr after injection. I also got very fatigued for a few hours. I took Ibuprofen to help with the headache and I took a nap to help with the fatigure.
This spontaneous report was received from a nurse refers to multiple unspecified patients of unknown age and gender. No information regarding the patient's medical history, concurrent conditions and concomitant therapies were reported. On unknown dates, the patients were vaccinated with improperly stored doses of VARIVAX which had the lot # L049536, expiry date: 08-DEC-2017; lot # L044526, expiry date: 09-NOV-2017 and L037562, expiry date: 29-SEP-2017 (route, dose and anatomical place of vaccination were not provided). No adverse effects were reported. The vaccines were exposed to temperature of 41 degree Fahrenheit for 10 hours. The temperature excursion was detected by a date logger. At the tie of this report, the vaccines were back in range. No product quality complaint (PQC) involved and no further information was provided. This is one of several reports received from the same reporter. Additional information has been requested.
Approximately 10 minutes after receiving the intranasal vaccine developed light headness (felt like she would pass out), bradycardia, generalized itching, "hot pink-bright red face.
got so so sick from the first Shingrix; I never went back for the second; This case was reported by a consumer via interactive digital media and described the occurrence of sickness in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingles vaccine (received at 50 years of age).   On an unknown date, the patient received the 1st dose of Shingrix and the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced sickness and incomplete course of vaccination. On an unknown date, the outcome of the sickness and incomplete course of vaccination were unknown.   It was unknown if the reporter considered the sickness to be related to Shingrix.  Additional details were provided as follows: The patient self reported the case. The age at vaccination was not reported. The age group was not reported but was captured as per vaccine indication. The patient stated, the vaccine do not prevent shingles and shingrix had horrid side effects. The patient received 1st dose of Shingrix and was sick. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR084176:same reporter
Patient had already recieved the J&J vaccine in June. On his consent form, he stated that he had not received any prior doses of a Covid vaccine. We cannot reach the patient to verify any adverse events
Coughing, sore throat, couldn't swallow easily, swollen throat, fever 101-102 degrees F, muscle/bone pain, increased HR.
DIZZINESS / LIGHTHEADEDNESS; FELT OUT OF IT; CHILLS; FEVER; HEADACHE; This spontaneous report received from a consumer concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the patient experienced dizziness / lightheadedness, felt out of it, chills, fever, and headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fever, chills, headache, dizziness / lightheadedness and felt out of it was not reported. This report was non-serious.
Information has been received from a physician concerning a patient (age and gender unknown) who was vaccinated with a dose of Zostavax (Oka/Merck). Subsequently the patient developed shingles after receiving Zostavax (Oka/Merck). No product quality complaint. Outcome of the patient unknown. Additional information has been requested.